Abstract:Hematopoiesis is a tightly regulated process that produces all adult blood cells and immune cells from multipotent hematopoietic stem cells (HSCs). HSCs usually remain quiescent, and in the presence of external stimuli like infection or inflammation, they undergo division and differentiation as a compensatory mechanism. Normal hematopoiesis is impacted by systemic inflammation, which causes HSCs to transition from quiescence to emergency myelopoiesis. At the molecular level, inflammatory cytokine signaling molecules such as tumor necrosis factor (TNF), interferons, interleukins, and toll-like receptors can all cause HSCs to multiply directly. These cytokines actively encourage HSC activation, proliferation, and differentiation during inflammation, which results in the generation and activation of immune cells required to combat acute injury. The bone marrow niche provides numerous soluble and stromal cell signals, which are essential for maintaining normal homeostasis and output of the bone marrow cells. Inflammatory signals also impact this bone marrow microenvironment called the HSC niche to regulate the inflammatory-induced hematopoiesis. Continuous pro-inflammatory cytokine and chemokine activation can have detrimental effects on the hematopoietic system, which can lead to cancer development, HSC depletion, and bone marrow failure. Reactive oxygen species (ROS), which damage DNA and ultimately lead to the transformation of HSCs into cancerous cells, are produced due to chronic inflammation. The biological elements of the HSC niche produce pro-inflammatory cytokines that cause clonal growth and the development of leukemic stem cells (LSCs) in hematological malignancies. The processes underlying how inflammation affects hematological malignancies are still not fully understood. In this review, we emphasize the effects of inflammation on normal hematopoiesis, the part it plays in the development and progression of hematological malignancies, and potential therapeutic applications for targeting these pathways for therapy in hematological malignancies.

Inflammation perturbs hematopoiesis by remodeling specific compartments of the bone marrow niche

Global transcriptomic profiling of the bone marrow stromal microenvironment during postnatal development, aging and inflammation

Inflammatory recruitment of healthy hematopoietic stem and progenitor cells in the acute myeloid leukemia niche

Immuno-Modulation of Hematopoietic Stem and Progenitor Cells in Inflammation

The role of inflammation in hematopoiesis and bone marrow failure: What can we learn from mouse models?

Inflammatory Mesenchymal Stromal Cells and IFN-responsive T cells are key mediators of human bone marrow niche remodeling in CHIP and MDS

A Single-Cell Hematopoietic Landscape Resolves 8 Lineage Trajectories and Defects in Kit Mutant Mice.

Towards an integrated understanding of inflammatory pathway influence on hematopoietic stem and progenitor cell differentiation

Single-cell time series analysis reveals the dynamics of HSPC response to inflammation

In situ mapping identifies distinct vascular niches for myelopoiesis

Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection

Single-cell and spatial transcriptomics approaches of the bone marrow microenvironment

Interferon-sensitized hematopoietic progenitors dynamically alter organismal immunity

Single-cell RNA sequencing identifies phenotypically, functionally, and anatomically distinct stromal niche populations in human bone marrow

The bone marrow microenvironment at single-cell resolution

Inflamm-Aging of Hematopoiesis, Hematopoietic Stem Cells, and the Bone Marrow Microenvironment

Resilient anatomy and local plasticity of naive and stress haematopoiesis

Identification of phenotypically, functionally, and anatomically distinct stromal niche populations in human bone marrow based on single-cell RNA sequencing

Inflammation, Aging and Hematopoiesis: A Complex Relationship

Characterization of Multicellular Niches Supporting Hematopoietic Stem Cells Within Distinct Zones

Inflammation as a driver of hematological malignancies